Male Breast Cancer

Area of Science:

• Oncology
• Men's Health
• Cancer Research

Background:

• Male breast cancer (MBC) is a rare malignancy, comprising less than 1% of all breast cancer diagnoses globally.
• Existing research on MBC is often limited by small study cohorts, necessitating data aggregation.
• Understanding MBC requires acknowledging both shared and distinct characteristics compared to female breast cancer.

Purpose of the Study:

• To provide a comprehensive overview of male breast cancer (MBC).
• To consolidate and analyze existing data on MBC incidence, etiology, and clinical presentation.
• To review current diagnostic, treatment, and prognostic factors specific to male breast cancer.

Main Methods:

• Systematic literature review and meta-analysis of existing small-scale studies on male breast cancer.
• Consolidation of data on incidence, etiology, clinical features, diagnosis, treatment, pathology, and survival.
• Analysis of prognostic factors influencing outcomes in male breast cancer patients.

Main Results:

• Male breast cancer (MBC) exhibits unique epidemiological and clinical features.
• Aggregated data from small studies reveal key insights into MBC's incidence and risk factors.
• Standard treatment protocols for female breast cancer are often adapted for male patients, with specific considerations for pathology and survival.

Conclusions:

• Male breast cancer (MBC) requires specialized attention due to its rarity and distinct characteristics.
• Further research and larger collaborative studies are needed to improve understanding and management of MBC.
• This review highlights the importance of consolidating data to inform clinical practice and improve outcomes for male breast cancer patients.